NovoEight Prices, Coupons, Copay Cards & Patient Assistance
NovoEight (antihemophilic factor) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hemophilia A.
NovoEight prices
Intravenous Powder For Injection
recombinant NovoEight intravenous powder for injection from $6.58 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $6.58 | $6.58 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
NovoEight Coupons, Copay Cards and Rebates
NovoEight offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Novoeight Co-pay Assistance Program
Eligible commercially insured patients may pay as little as $0 per fill with a savings of up to $15,000 per calendar year
- Applies to:
- Novoeight
- Number of uses:
- per prescription per calendar year
Form more information phone: 844-668-6732 or Visit website
Novoeight Free Trial Prescription Program
Eligible commercially insured patients may receive a trial prescription of up to 6 doses.
- Applies to:
- Novoeight
- Number of uses:
- 1 time
Form more information phone: 844-668-6732 or Visit website
Patient Assistance & Copay Programs for NovoEight
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Novoeight (antihemophilic factor recombinant) Injection; IV Lyophilized powder
More information please phone: 866-316-7263 Visit website
Provider: Novo Nordisk Rare Bleeding Disorders Patient Assistance Program
Eligibility requirements:- Must be uninsured
- At or below 400% of FPL
- Medically appropriate condition/diagnosis
- The patient must be a US citizen or legal resident.
- Co-payment assistance, and patient assistance programs are available for eligible patients. Free Trial Program: Contact Program for details
- Novoeight (antihemophilic factor recombinant) Injection; IV Lyophilized powder
More information please phone: 844-668-6732 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about NovoEight (antihemophilic factor)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Other brands
Altuviiio, Advate, Kovaltry, Xyntha, ... +14 more
Professional resources
- Novoeight prescribing information
- Antihemophilic Factor (recombinant), PEGylated-aucl (AHFS Monograph)
Other brands
Altuviiio, Advate, Kovaltry, Xyntha, ... +12 more